UCLA Health hospitals rank No. 1 in L.A. and state, No. 3 in nation

UCLA Health hospitals  are No. 1 in both Los Angeles and California and rose to No. 3 nationally in an annual evaluation published today by U.S. News&World Report. It is the first time UCLA Health has been ranked so highly nationally while also holding the top positions in both the city and the state.UCLA Health once again earned a coveted spot on thenational honor roll, which names only the 20 hospitals that provide the highest-quality care across a wide range of procedures and conditions.UCLA Health earnedtop 10 rankings in 12 specialties: diabetes and endocrinology (3), gastroenterology/gastrointestinal surgery (4), geriatrics (4), pulmonology and lung surgery (4), ophthalmology (5), orthopaedics (5), psychiatry (5), cancer (8), neurology and neurosurgery (8), urology (8), cardiology and heart surgery (9), and rheumatology (9).Read the full news release.
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news

Related Links:

In conclusion, inhibiting the lysosomal oxidation of LDL in atherosclerotic lesions by antioxidants targeted at lysosomes causes the regression of atherosclerosis and improves liver and muscle characteristics in mice and might be a promising novel therapy for atherosclerosis in patients. NANOG Expression versus Cellular Senescence https://www.fightaging.org/archives/2021/09/nanog-expression-versus-cellular-senescence/ Are there many strategies that can reverse cellular senescence? There are certainly strategies that can lower levels of cellular senescence over time, both in cell cultures and in living an...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
Cancers are regarded as one of the main causes of death and result in high health burden worldwide. The management of cancer include chemotherapy, surgery and radiotherapy. The chemotherapy, which involves the...
Source: Cancer Cell International - Category: Cancer & Oncology Authors: Tags: Review Source Type: research
This study sought to assess an innovative user-centered design approach to improving clinical care quality, focusing on the use cases of de-intensifying non-beneficial care within the following areas: (1) de-intensifying diabetes treatment in high-risk patients; (2) stopping screening for carotid artery stenosis in asymptomatic patients; and (3) stopping colorectal cancer screening in average-risk, older adults.MethodsThe user-centered design approach, consisting of patient and patient-clinician charrettes (defined as intensive workshops where key stakeholders collaborate to develop creative solutions to a specific problem...
Source: Journal of General Internal Medicine - Category: Internal Medicine Source Type: research
By HANS DUVEFELT Leo Dufour is not a diabetic. He is in his mid 50s, a light smoker with hypertension and a known hiatal hernia. He has had occasional heartburn and has taken famotidine for a few years along with his blood pressure and cholesterol pills. Over the past few months, he started to experience a lot more heartburn, belching and bloating. Adding pantoprazole did nothing for him. I referred him to a local surgeon who did an upper endoscopy. This did not reveal much, except some retained food in his stomach. A gastric emptying study showed severe gastroparesis. The surgeon offered him a trial of metoclopra...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Medical Practice Physicians Primary Care Hans Duvefelt Source Type: blogs
In conclusion, CTS has a comparable impact on quality of life as compared with other diseases, and CTR has the potential to substantially improve patient's HRQoL at a fairly modest cost.Level of evidence: III.PMID:34525853 | DOI:10.1177/17531934211045634
Source: Hand Surgery - Category: Surgery Authors: Source Type: research
Curr Pharm Des. 2021 Aug 25. doi: 10.2174/1381612827666210825114403. Online ahead of print.ABSTRACTImplantable microfluidic devices are milestones in developing devices that can either measure parameters like ocular pressure and blood glucose level or deliver various components for therapeutic needs or behavioral modification. Researchers are currently focusing on the miniaturization of almost all its tools for a better healthcare platform. Implantable microfluidic devices are a combination of various systems including, but not limited to, microfluidic platforms, reservoirs, sensors, and actuators, implanted inside the bod...
Source: Current Pharmaceutical Design - Category: Drugs & Pharmacology Authors: Source Type: research
In conclusion, CTS has a comparable impact on quality of life as compared with other diseases, and CTR has the potential to substantially improve patient's HRQoL at a fairly modest cost.Level of evidence: III.PMID:34525853 | DOI:10.1177/17531934211045634
Source: Hand Surgery - Category: Surgery Authors: Source Type: research
Curr Pharm Des. 2021 Aug 25. doi: 10.2174/1381612827666210825114403. Online ahead of print.ABSTRACTImplantable microfluidic devices are milestones in developing devices that can either measure parameters like ocular pressure and blood glucose level or deliver various components for therapeutic needs or behavioral modification. Researchers are currently focusing on the miniaturization of almost all its tools for a better healthcare platform. Implantable microfluidic devices are a combination of various systems including, but not limited to, microfluidic platforms, reservoirs, sensors, and actuators, implanted inside the bod...
Source: Current Pharmaceutical Design - Category: Drugs & Pharmacology Authors: Source Type: research
Might menopausal hormone therapy help protect against the development of colorectal cancer? This review examines the evidence.Clinical Endocrinology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
ConclusionsOur cellular findings indicate that polyamine inhibition should be explored in patient population as a target for future chemotherapeutics in diabetic breast cancer.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Cardiology | Diabetes | Endocrinology | Gastroenterology | Geriatrics | Heart | Hospitals | Neurology | Neurosurgery | Opthalmology | Orthopaedics | Psychiatry | Rheumatology | Universities & Medical Training | Urology & Nephrology